News

Development of immunohistochemistry assays for oncology

Development of immunohistochemistry assays for oncology

Horizon Discovery Group has entered into an agreement with Roche Diagnostics to assist in the development of immunohistochemistry (IHC) assays. Under the terms of the agreement, Horizon will develop and provide reference standard material expressing neurotrophic tropomyosin receptor kinase (NTRK) fusion biomarkers.

Features

Facilitating the prepared  mind: highlights from the  Congress science programme

Facilitating the prepared mind: highlights from the Congress science programme

The Biomedical Science Congress scientific programme once again provided a compelling reason to attend the twelfth biennial event, held last autumn at the ICC in Birmingham. Here, Pathology in Practice takes a brief look at some content highlights.

Expression of uncertainty in measurement: combining standard uncertainties

Expression of uncertainty in measurement: combining standard uncertainties

The fifth in a series of articles on individual aspects of the assessment of uncertainty of measurement sees Stephen MacDonald consider some of the more difficult questions that may be faced in relation to measurement uncertainty

Upcoming Events

Infection Prevention And Control 2018

The Brewery, 52 Chiswell Street, London EC1Y 4SD
21 February 2018

British Society for Microbial Technology Annual Scientific Conference

Public Health England, Colindale, London
18 May 2018

Pathology Horizons 2018 Conference

Lough Erne Resort, Co. Fermanagh, Northern Ireland
September 13-15

Microbe 2018

Hilton Hotel, Sheffield
21-23 September 2018

Infection Prevention 2018

Scottish Events Campus, Glasgow
30 September - 2 October 2018

Latest Issue

Pathology In Practice

Pathology In Practice

Feb 2018

Experience drives revolution... the NanoZoomer S360

Register now to apply for regular copies of Pathology In Practice and free access to premium content, as well as our regular newsletters.